The call for late breaking poster submissions has now closed.
The International Federation of Dental Hygienists (IFDH), in collaboration with the Dental Hygienists Association of Australia (DHAA), invites colleagues from the international community to submit their research abstracts to be considered for the poster session at the 21st International Symposium on Dental Hygiene. Poster sessions will be held on August 16, 2019 in Brisbane, Australia.
Poster sessions are an opportunity to share original research, learn new concepts, network and exchange ideas, and stay current on relevant information. Research presented should pertain to the theme of the conference, LEAD: Leadership, Empowerment, Advances, and Diversity; be pertinent to published national research agendas; and, be significant to advancing the dental hygiene body of knowledge.
Abstracts that have been previously presented and published will be considered; however, they must be properly acknowledged by providing the citation to that abstract. Individuals submitting abstracts may be the primary presenter on only one abstract, but may be the co-author on other abstracts. Presenters are not required to be the principal investigator of the study, but should be a member of the research team. Presenters may be graduate students, clinicians, educators and researchers.
All abstracts must follow the abstract template and be submitted through the Poster Abstract Submission Portal by 8 October 2018. Please note that the closing date for abstract submissions will not be extended.
Submitting your abstractClick here to download the abstract template
You can access the online submission form using the 'Submit Poster Abstract' button above. You will need to set up a new user account and create a log in and password, before you can submit your abstract. You will be able to use that log in and password to re-enter the submission portal to make edits to your draft abstract up until the submission deadline.
You will be required to submit your contact details and details of your abstract (Abstract Title, Authors, Topic, etc.). At the end of this form you should upload your abstract as a document file.
After submitting your abstract, you will receive a confirmation of poster abstract submission email from the ISDH 2019 Symposium Secretariat.
Please ensure that all the required information is completed as requested. If you experience any problems during the online submission process, please contact the ISDH 2019 Symposium Secretariat at email@example.com or by telephone on + 61 7 3255 1002.
All accepted poster abstracts will be made available to Symposium delegates. Authors are responsible for proof reading and submitting an abstract without errors, as they will be reproduced in the format they were submitted. The corresponding author is responsible for the abstract content. This author is the contact person for submission or communication purposes and is also responsible for disseminating information related to the co-authors.
All enquiries regarding abstract submissions should be emailed to firstname.lastname@example.org
Dates and Deadlines
|Second Call for Abstracts open||1 September 2018|
|Call for Abstracts close||8 October 2018|
|Notifications to Authors||22 October 2018|
Abstract Submission Guidelines
- Please read all instructions before typing the abstracts on the form.
- Proof read your abstract carefully. The abstract will be reproduced directly from this form.
- The typeface character should be Arial and font size 12. Dot matrix print is not acceptable. Type must be in black.
- The maximum number of words for an abstract is 400; no exceptions.
- Abstracts must be written in English.
- The abstract must be single-spaced. Include a double space between each paragraph. Use a narrative text, and do not include any graphs, tables or references.
- Abstracts must be submitted using the Poster Abstracts Submission Portal.
- Presentations of accepted abstracts must reflect the abstract’s content. All presenters for the poster session must register for the meeting at the appropriate registration fee.
- All posters must be accompanied by a presenter who is a member of the research team.
- Funding support must be identified in the last sentence, i.e. “Funding for this project through______”.
Abstracts may be submitted under one of the following presentation types:
- New Program
- New Research
- Systematic Review
Abstract Selection Criteria
Abstracts will be selected on the basis of the scientific quality of the work as judged by the submission. Original work is required, such as systematic reviews, new programs or new research. Submissions will undergo a double-blind review process. Each abstract must be no more than 400 words and contain the following elements:
|Purpose/Goals||Program purpose/goals are clearly defined.|
|Significance||The significance of the program is clearly stated.|
|Approach/Key Features||Key features, structure, systems and/or process are clearly described.|
|Evaluation||The evaluation plan is well developed, or the results demonstrate effectiveness.|
|Problem statement||Statement of the problem and study significance are provided.|
|Purpose||Study purposes are clearly defined.|
|Methods||Methodology (design, sampling and intervention) is outlined and appropriate for the study.|
|Results||Results including data analysis (or plan for analysis) are included.|
|Conclusion||Conclusions (or preliminary findings) are supported by the results and stated clearly.|
|IRB approval||IRB approval is required for all studies involving human subjects or animals. Provide the name of the entity approving the research and the approval number.|
|Studies in progress||Studies in-progress at the time of submission must include a detailed plan for statistical analysis and preliminary findings. Final results must be available by the final revision due (TBD).|
|Statement||New research must support research priorities and/or provide the scientific basis for clinical practice.|
|Objective||A clearly formulated question is included.|
|Search Strategy/Selection Criteria||Explicit methods of how studies were identified, selected and critically appraised relevant research.|
|Data Collection and Analysis||Methods used to collect and analyze data from the studies that are included in the review.|
|Main Results||Number and type of studies included and summary of results.|
|Conclusion||Brief highlight of findings, type of evidence and recommendations.|
|Free of bias||The review process is comprehensive and unbiased.|
|Statement||Findings support research priorities and/or provide the scientific basis for clinical practice.|
Terms and Conditions
The submission of an abstract indicates an understanding of the following rules for participation in the Symposium:
- All author(s) approve submitting this work for presentation
- The author(s) transfer(s) all copyright ownership of the abstract to the Symposium
- The author(s) agree(s) to materially confine their presentations to information in the abstract if accepted for presentation. If an author has more than one abstract accepted, each presentation will be materially confined to the information in the abstract selected for the specific session
- At least one author will be available to present the abstract if selected for the program. The authors will immediately notify the Symposium Secretariat if they are unable to present an abstract or if the presenting author is changed. The organisers reserve the right to remove a presentation from the program
Notification to Authors
- Corresponding authors will be notified of acceptance by 30 June 2018. All accepted abstracts/posters must be presented by at least one author
- Abstracts are submitted to an allocated session, it is not possible to change the date, time or type of presentation
- Presenters must register by 31 October 2018.